A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity.
This review is concerned with evaluating the toxicity associated with human exposure to silver and gold nanoparticles (NPs), due to the relative abundance of toxicity data available for these particles, when compared to other metal particulates. This has allowed knowledge on the current understanding of the field to be gained, and has demonstrated where gaps in knowledge are. It is anticipated that evaluating the hazards associated with silver and gold particles will ultimately enable risk assessments to be completed, by combining this information with knowledge on the level of human exposure. The quantity of available hazard information for metals is greatest for silver particulates, due to its widespread inclusion within a number of diverse products (including clothes and wound dressings), which primarily arises from its antibacterial behaviour. Gold has been used on numerous occasions to assess the biodistribution and cellular uptake of NPs following exposure. Inflammatory, oxidative, genotoxic, and cytotoxic consequences are associated with silver particulate exposure, and are inherently linked. The primary site of gold and silver particulate accumulation has been consistently demonstrated to be the liver, and it is therefore relevant that a number of in vitro investigations have focused on this potential target organ. However, in general there is a lack of in vivo and in vitro toxicity information that allows correlations between the findings to be made. Instead a focus on the tissue distribution of particles following exposure is evident within the available literature, which can be useful in directing appropriate in vitro experimentation by revealing potential target sites of toxicity. The experimental design has the potential to impact on the toxicological observations, and in particular the use of excessively high particle concentrations has been observed. As witnessed for other particle types, gold and silver particle sizes are influential in dictating the observed toxicity, with smaller particles exhibiting a greater response than their larger counterparts, and this is likely to be driven by differences in particle surface area, when administered at an equal-mass dose. A major obstacle, at present, is deciphering whether the responses related to silver nanoparticulate exposure derive from their small size, or particle dissolution contributes to the observed toxicity. Alternatively, a combination of both may be responsible, as the release of ions would be expected to be greater for smaller particles.
Johnston
Helinor J
HJ
Centre for Nano Safety, School of Life Sciences, Edinburgh Napier University, Edinburgh, UK. Helinor.johnston@defra.gsi.gov.uk
Hutchison
Gary
G
Christensen
Frans M
FM
Peters
Sheona
S
Hankin
Steve
S
Stone
Vicki
V
D004391:Dust / Q000032:analysis; D006046:Gold / Q000494:pharmacology*; D006801:Humans; D008670:Metals / Q000494:pharmacology*; D053758:Nanoparticles / Q000633:toxicity*; D010316:Particle Size; D052638:Particulate Matter / Q000633:toxicity; D018570:Risk Assessment; D012834:Silver / Q000494:pharmacology*; D018030:Silver Compounds / Q000494:pharmacology*; D014018:Tissue Distribution
D004391:Dust; D008670:Metals; D052638:Particulate Matter; D018030:Silver Compounds; D012834:Silver; D006046:Gold